{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:52Z","timestamp":1793407852466,"version":"4.5.0"},"reference-count":146,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The gastrointestinal and respiratory systems are closely linked in different ways, including from the embryological, anatomical, cellular, and physiological angles. The highest number (and various types) of microorganisms live in the large intestine\/colon, and constitute the normal microbiota in healthy people. Adverse alterations of the microbiota or dysbiosis can lead to chronic inflammation. If this detrimental condition persists, a sequence of pathological events can occur, such as inflammatory bowel disease, dysplasia or premalignant changes, and finally, cancer. One of the most commonly identified bacteria in both inflammatory bowel disease and colon cancer is Escherichia coli. On the other hand, patients with inflammatory bowel disease are at risk of several other diseases\u2014both intestinal (such as malnutrition and intestinal obstruction, besides cancer) and extraintestinal (such as arthritis, bronchiectasis, and cancer risk). Cancers of the lung and colon are the two most common malignancies occurring worldwide (except for female breast cancer). Like the bacterial role in colon cancer, many studies have shown a link between chronic Chlamydia pneumoniae infection and lung cancer. However, in colon cancer, genotoxic colibactin-producing E. coli belonging to the B2 phylogroup may promote tumorigenesis. Furthermore, E. coli is believed to play an important role in the dissemination of cancer cells from the primary colonic site. Currently, seven enteric pathogenic E. coli subtypes have been described. Conversely, three Chlamydiae can cause infections in humans (C. trachomatis may increase the risk of cervical and ovarian cancers). Nonetheless, striking genomic plasticity and genetic modifications allow E. coli to constantly adjust to the surrounding environment. Consequently, E. coli becomes resistant to antibiotics and difficult to manage. To solve this problem, scientists are thinking of utilizing suitable lytic bacteriophages (viruses that infect and kill bacteria). Several bacteriophages of E. coli and Chlamydia species are being evaluated for this purpose.<\/jats:p>","DOI":"10.3390\/medicina60091515","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:43:13Z","timestamp":1726652593000},"page":"1515","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections"],"prefix":"10.3390","volume":"60","author":[{"given":"Amitabha","family":"Ray","sequence":"first","affiliation":[{"name":"School of Health Professions, D\u2019Youville University, 320 Porter Ave, Buffalo, NY 14201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Moore","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Glenville State University, Glenville, WV 26351, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayalu S. L.","family":"Naik","sequence":"additional","affiliation":[{"name":"ICMR National Institute of Traditional Medicine, Belagavi 590010, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Borsch","sequence":"additional","affiliation":[{"name":"Lake Erie College of Osteopathic Medicine at Seton Hill, Greensburg, PA 15601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.earlhumdev.2007.09.007","article-title":"Lung growth and development","volume":"83","author":"Joshi","year":"2007","journal-title":"Early Hum. Dev."},{"key":"ref_2","unstructured":"Pawlina, W. (2024). Histology, Wolters Kluwer. [9th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"R417","DOI":"10.1530\/ERC-20-0122","article-title":"Neuroendocrine neoplasms of lung, pancreas and gut: A morphology-based comparison","volume":"27","author":"Kasajima","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: Recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.annonc.2022.02.226","article-title":"Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel","volume":"33","author":"Yu","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/ecco-jcc\/jjab217","article-title":"Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel disease: An ECCO CONFER multicentre case series","volume":"16","author":"Festa","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11154-020-09589-y","article-title":"From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? Rev","volume":"22","author":"Vitale","year":"2021","journal-title":"Endocr. Metab. Disord"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ibd.20172","article-title":"Carcinoid tumors are 15 times more common in patients with Crohn\u2019s disease","volume":"13","author":"West","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/ecco-jcc\/jjab102","article-title":"Inflammatory bowel disease-associated colorectal cancer: Translational risks from mechanisms to medicines","volume":"15","author":"Porter","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gao, H., Zheng, S., Yuan, X., Xie, J., and Xu, L. (2023). Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: A Mendelian randomization study. BMC Med., 21.","DOI":"10.1186\/s12916-023-03096-y"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/00365521.2023.2238101","article-title":"Risk of uterine cervical cancer in inflammatory bowel disease: A systematic review and meta-analysis","volume":"58","author":"Kim","year":"2023","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cgh.2020.08.015","article-title":"The risk of extraintestinal cancer in inflammatory bowel disease: A systematic review and meta-analysis of population-based cohort studies","volume":"19","author":"Lo","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cavalli, C.A.M., Gabbiadini, R., Dal Buono, A., Quadarella, A., De Marco, A., Repici, A., Bezzio, C., Simonetta, E., Aliberti, S., and Armuzzi, A. (2023). Lung involvement in inflammatory bowel diseases: Shared pathways and unwanted connections. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196419"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/MIB.0000000000000788","article-title":"Bacterial intestinal superinfections in inflammatory bowel diseases beyond clostridum difficile","volume":"22","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, Y., Cui, W., Li, X., and Yang, H. (2021). Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.761981"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MEG.0000000000001605","article-title":"Inflammatory bowel disease versus Chlamydia trachomatis infection: A case report and revision of the literature","volume":"32","author":"Neri","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_18","first-page":"820","article-title":"Infectious proctitis and perianal disease: A gaze beyond inflammatory bowel disease","volume":"38","author":"Quera","year":"2021","journal-title":"Rev. Chilena Infectol."},{"key":"ref_19","first-page":"587","article-title":"Lymphogranuloma venereum: An emerging problem in Poland","volume":"39","author":"Smolarczyk","year":"2022","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00042737-200608000-00015","article-title":"Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease","volume":"18","author":"Arni","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1440-1746.2002.02793.x","article-title":"Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls","volume":"17","author":"Chen","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Howe, S.E., Shillova, N., and Konjufca, V. (2019). Dissemination of Chlamydia from the reproductive tract to the gastro-intestinal tract occurs in stages and relies on Chlamydia transport by host cells. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008207"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.tim.2021.03.011","article-title":"Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization","volume":"29","author":"Zhong","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer","volume":"28","author":"Quaglio","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lopez, L.R., Ahn, J.H., Alves, T., and Arthur, J.C. (2022). Microenvironmental factors that shape bacterial metabolites in inflammatory bowel disease. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.934619"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3109\/00365521.2016.1161067","article-title":"Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: A randomised controlled trial","volume":"51","author":"Bengtsson","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5152\/tjg.2019.18426","article-title":"Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease","volume":"30","author":"Fan","year":"2019","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cgh.2014.10.031","article-title":"The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn\u2019s disease","volume":"13","author":"Fedorak","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"63","author":"Matsuoka","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5507\/bp.2016.044","article-title":"The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study","volume":"160","author":"Palumbo","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4166\/kjg.2015.65.4.215","article-title":"Effects of probiotics on gut microbiota in patients with inflammatory bowel disease: A double-blind, placebo-controlled clinical trial","volume":"65","author":"Shadnoush","year":"2015","journal-title":"Korean J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/den.12553","article-title":"Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial","volume":"28","author":"Tamaki","year":"2016","journal-title":"Dig. Endosc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lfs.2017.05.016","article-title":"Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli","volume":"180","author":"Khan","year":"2017","journal-title":"Life Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/ecco-jcc\/jjac071","article-title":"Escherichia coli strains from patients with inflammatory bowel diseases have disease-specific genomic adaptations","volume":"16","author":"Dubinsky","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"ref_36","first-page":"3","article-title":"coli as an all-rounder: The thin line between commensalism and pathogenicity","volume":"358","author":"Leimbach","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Santos, A.C.M., Santos, F.F., Silva, R.M., and Gomes, T.A.T. (2020). Diversity of hybrid- and hetero-pathogenic Escherichia coli and their potential implication in more severe diseases. Front. Cell. Infect Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00339"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14787210.2015.1028365","article-title":"Multidrug-resistant Escherichia coli in Asia: Epidemiology and management","volume":"13","author":"Sidjabat","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2004.03.054","article-title":"Enhanced Escherichia coli adherence and invasion in Crohn\u2019s disease and colon cancer","volume":"127","author":"Martin","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijsu.2015.04.077","article-title":"Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A prospective cohort study","volume":"18","author":"Magdy","year":"2015","journal-title":"Int. J. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7883\/yoken.JJID.2020.066","article-title":"Characterization of colibactin-producing Escherichia coli isolated from Japanese patients with colorectal cancer","volume":"73","author":"Yoshikawa","year":"2020","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/1389201022666210910094827","article-title":"Escherichia coli and colorectal cancer: Unfolding the enigmatic relationship","volume":"23","author":"Nouri","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/cas.16088","article-title":"Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients","volume":"115","author":"Miyasaka","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1038\/s41467-023-43329-5","article-title":"Contribution of pks(+) E. coli mutations to colorectal carcinogenesis","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-60327-492-0_16","article-title":"Acquired risk factors for colorectal cancer","volume":"472","author":"Lin","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0889-8553(02)00057-2","article-title":"Modifiable risk factors for colon cancer","volume":"31","author":"Giovannucci","year":"2002","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/jgh.16462","article-title":"The effects of pks(+) Escherichia coli and bile acid in colorectal tumorigenesis among people with cholelithiasis or cholecystectomy","volume":"39","author":"Pan","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2320291","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"Dalmasso","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"ofae106","DOI":"10.1093\/ofid\/ofae106","article-title":"Fecal carriage of colibactin-encoding Escherichia coli associated with colorectal cancer among a student populace","volume":"11","author":"Akinduti","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2310215","DOI":"10.1080\/19490976.2024.2310215","article-title":"Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence","volume":"16","author":"Dalmasso","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bos\u00e1k, J., Kohoutov\u00e1, D., Hrala, M., K\u0159enov\u00e1, J., Mor\u00e1vkov\u00e1, P., Rejchrt, S., Bure\u0161, J., and \u0160majs, D. (2023). Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1141619"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/1040841X.2018.1481013","article-title":"E. coli and colorectal cancer: A complex relationship that deserves a critical mindset","volume":"44","author":"Wassenaar","year":"2018","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2205563","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e0000124","DOI":"10.1128\/iai.00001-24","article-title":"Enterohemorrhagic Escherichia coli effector EspF triggers oxidative DNA lesions in intestinal epithelial cells","volume":"92","author":"Fang","year":"2024","journal-title":"Infect. Immun."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Nouri, R., Hasani, A., Shirazi, K.M., Sefiadn, F.Y., Mazraeh, F.N., Sattarpour, S., and Rezaee, M.A. (2024). Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains. Diagn. Microbiol. Infect. Dis., 109.","DOI":"10.1016\/j.diagmicrobio.2024.116229"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ayabe, R.I., and White, M.G. (2024). Metastasis and the microbiome: The impact of bacteria in disseminated colorectal cancer. Front. Biosci. Landmark Ed., 29.","DOI":"10.31083\/j.fbl2904152"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1903825","article-title":"Association of pre-diagnostic antibody responses to Escherichia coli and Bacteroides fragilis toxin proteins with colorectal cancer in a European cohort","volume":"13","author":"Butt","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1080\/21655979.2021.1972077","article-title":"The gut microbial diversity of colon cancer patients and the clinical significance","volume":"12","author":"He","year":"2021","journal-title":"Bioengineered"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cas.15196","article-title":"Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan","volume":"113","author":"Iwasaki","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Iyadorai, T., Mariappan, V., Vellasamy, K.M., Wanyiri, J.W., Roslani, A.C., Lee, G.K., Sears, C., and Vadivelu, J. (2020). Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228217"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kamali Dolatabadi, R., Fazeli, H., Emami, M.H., Karbasizade, V., Maghool, F., Fahim, A., and Rahimi, H. (2022). Phenotypic and genotypic characterization of clinical isolates of intracellular adherent-invasive Escherichia coli among different stages, family history, and treated colorectal cancer patients in Iran. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.938477"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Siles, M., Camprub\u00ed-Font, C., G\u00f3mez Del Pulgar, E.M., Sabat Mir, M., Busquets, D., Sanz, Y., and Martinez-Medina, M. (2022). Prevalence, abundance, and virulence of adherent-invasive Escherichia coli in ulcerative colitis, colorectal cancer, and coeliac disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.748839"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Messaritakis, I., Vogiatzoglou, K., Tsantaki, K., Ntretaki, A., Sfakianaki, M., Koulouridi, A., Tsiaoussis, J., Mavroudis, D., and Souglakos, J. (2020). The prognostic value of the detection of microbial translocation in the blood of colorectal cancer patients. Cancers, 12.","DOI":"10.3390\/cancers12041058"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Mirzarazi, M., Bashiri, S., Hashemi, A., Vahidi, M., Kazemi, B., and Bandehpour, M. (2022). The OmpA of commensal Escherichia coli of CRC patients affects apoptosis of the HCT116 colon cancer cell line. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02540-y"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.3748\/wjg.v30.i21.2817","article-title":"Preclinical and clinical evidence of the association of colibactin-producing Escherichia coli with anxiety and depression in colon cancer","volume":"30","author":"Rondepierre","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4149\/neo_2018_1801174N34","article-title":"The study of bacteria in biopsies from Slovak colorectal adenoma and carcinoma patients","volume":"65","author":"Wachsmannova","year":"2018","journal-title":"Neoplasma"},{"key":"ref_67","unstructured":"Wegener, H.C. (2012). Antibiotic resistance\u2014Linking human and animal health. Improving Food Safety through a One Health Approach, Institute of Medicine (US)\/The National Academies Press. A15."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"106433","DOI":"10.1016\/j.ijantimicag.2021.106433","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: A \u2018One Health\u2019 study","volume":"58","author":"Mazzolini","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.prevetmed.2014.12.005","article-title":"Transmission of antibiotic-resistant Escherichia coli between cattle, humans and the environment in peri-urban livestock keeping communities in Morogoro, Tanzania","volume":"118","author":"Lupindu","year":"2015","journal-title":"Prev. Vet. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/fpd.2020.2830","article-title":"Occurrence, molecular characteristics, and antimicrobial resistance of Escherichia coli O157 in cattle, beef, and humans in Bishoftu Town, Central Ethiopia","volume":"18","author":"Gutema","year":"2021","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sebastian, S., Tom, A.A., Babu, J.A., and Joshy, M. (2021). Antibiotic resistance in Escherichia coli isolates from poultry environment and UTI patients in Kerala, India: A comparison study. Comp. Immunol. Microbiol. Infect. Dis., 75.","DOI":"10.1016\/j.cimid.2021.101614"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/dkz507","article-title":"Transmission of ESBL-producing Escherichia coli between broilers and humans on broiler farms","volume":"75","author":"Dierikx","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e01613-20","DOI":"10.1128\/AEM.01613-20","article-title":"Carriage of extended-spectrum-beta-lactamase- and AmpC beta-lactamase-producing Escherichia coli strains from humans and pets in the same households","volume":"86","author":"Benschop","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Marchetti, L., Buldain, D., Gortari Castillo, L., Buchamer, A., Chirino-Trejo, M., and Mestorino, N. (2021). Pet and stray dogs as reservoirs of antimicrobial-resistant Escherichia coli. Int. J. Microbiol., 2021.","DOI":"10.1155\/2021\/6664557"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e026072","DOI":"10.1136\/bmjopen-2018-026072","article-title":"Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010\u20132016: A retrospective observational study","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S1473-3099(21)00069-4","article-title":"Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): A quasi-experimental, ecological, data linkage study","volume":"21","author":"Aliabadi","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1473-3099(19)30573-0","article-title":"Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in the community: An interrupted time-series analysis","volume":"20","author":"Turmo","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","first-page":"110","article-title":"Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"31","author":"Grau","year":"2018","journal-title":"Rev. Esp. Quimioter. Span. J. Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ziv-On, E., Friger, M.D., Saidel-Odes, L., Borer, A., Shimoni, O., Nikonov, A., and Nesher, L. (2021). Impact of an antibiotic stewardship program on the incidence of resistant Escherichia coli: A quasi-experimental study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020179"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.ARBA-0003-2017","article-title":"Antimicrobial resistance in Chlamydiales, Rickettsia, Coxiella, and other intracellular pathogens","volume":"6","author":"Vanrompay","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-5793(99)00563-3","article-title":"Obligate intracellular parasites: Rickettsia prowazekii and Chlamydia trachomatis","volume":"452","author":"Zomorodipour","year":"1999","journal-title":"FEBS. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1128\/JB.186.3.683-691.2004","article-title":"ATP\/ADP translocases: A common feature of obligate intracellular amoebal symbionts related to Chlamydiae and Rickettsiae","volume":"186","author":"Linka","year":"2004","journal-title":"J. Bacteriol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Samanta, D., Mulye, M., Clemente, T.M., Justis, A.V., and Gilk, S.D. (2017). Manipulation of host cholesterol by obligate intracellular bacteria. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00165"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ray, A., Moore, T.F., Pandit, R., Burke, A.D., and Borsch, D.M. (2023). An overview of selected bacterial infections in cancer, their virulence factors, and some aspects of infection management. Biology, 12.","DOI":"10.3390\/biology12070963"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<31::AID-IJC6>3.0.CO;2-1","article-title":"Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer","volume":"74","author":"Laurila","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1699-0463.1999.tb01478.x","article-title":"Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study","volume":"107","author":"Koyi","year":"1999","journal-title":"APMIS"},{"key":"ref_87","first-page":"1263","article-title":"Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer","volume":"9","author":"Jackson","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1099\/jmm.0.04845-0","article-title":"Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: A case-control study","volume":"52","author":"Kocazeybek","year":"2003","journal-title":"J. Med. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Xu, X., Liu, Z., Xiong, W., Qiu, M., Kang, S., Xu, Q., Cai, L., and He, F. (2020). Combined and interaction effect of Chlamydia pneumoniae infection and smoking on lung cancer: A case-control study in Southeast China. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07418-8"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.31557\/APJCP.2023.24.2.659","article-title":"Assessment of the association of Chlamydia e pneumoniae infection with lung cancer in a Moroccan patients\u2019 cohort","volume":"24","author":"Chebak","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1759-7714.2010.00021.x","article-title":"Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China","volume":"1","author":"Liu","year":"2010","journal-title":"Thorac. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3934\/publichealth.2023044","article-title":"Microbial infections as potential risk factors for lung cancer: Investigating the role of human papillomavirus and chlamydia pneumoniae","volume":"10","author":"Drokow","year":"2023","journal-title":"AIMS Public Health"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13027-022-00425-3","article-title":"Chlamydia pneumoniae infections and development of lung cancer: Systematic review","volume":"17","author":"Premachandra","year":"2022","journal-title":"Infect. Agent. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1158\/1055-9965.EPI-09-1261","article-title":"Chlamydia pneumoniae infection and risk for lung cancer","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1309\/AJCPXMDRT1SY6KIV","article-title":"Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions","volume":"135","author":"Aigelsreiter","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1749-8090-6-137","article-title":"Bacterial and fungal microflora in surgically removed lung cancer samples","volume":"6","author":"Apostolou","year":"2011","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.30802\/AALAS-CM-24-000002","article-title":"Chlamydia muridarum associated pulmonary and urogenital disease and pathology in a colony of enzootically infected Il12rb2 deficient and Stat1 knockout mice","volume":"74","author":"Mishkin","year":"2024","journal-title":"Comp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.7314\/APJCP.2012.13.6.2819","article-title":"An experimental model for induction of lung cancer in rats by Chlamydia pneumoniae","volume":"13","author":"Chu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_99","first-page":"185","article-title":"Transforming activities of Chlamydia pneumoniae in human mesothelial cells","volume":"17","author":"Rizzo","year":"2014","journal-title":"Int. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4238\/2014.April.14.8","article-title":"Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer","volume":"13","author":"Chu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Chen, Z., Zhuang, J., Liu, M., Xu, X., Liu, Y., Yang, S., Xie, J., Lin, N., Lai, F., and He, F. (2024). Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: A time-to-deterioration model. BMC Pulm. Med., 24.","DOI":"10.1186\/s12890-024-02860-x"},{"key":"ref_102","first-page":"132","article-title":"Correlation between Chlamydia pneumoniae IgG positive in lung cancer patients and cytokines related to radiation-induced pulmonary lesion","volume":"14","author":"Zhang","year":"2011","journal-title":"Zhongguo Fei Ai Za Zhi Chin. J. Lung Cancer"},{"key":"ref_103","first-page":"329","article-title":"Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae","volume":"58","author":"Plecko","year":"2004","journal-title":"Acta Med. Croat."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2020.03.015","article-title":"High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection","volume":"96","author":"Shao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Lu, H., Yuan, J., Wu, Z., Wang, L., Wu, S., Chen, Q., Zhang, Z., Chen, Z., Zou, X., and Hu, Q. (2023). Distribution of drug-resistant genes in alveolar lavage fluid from patients with psittacosis and traceability analysis of causative organisms. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1182604"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e1004","DOI":"10.1093\/cid\/ciab067","article-title":"Transcontinental Dissemination of the L2b\/D-Da Recombinant Chlamydia trachomatis lymphogranuloma venereum (LGV) Strain: Need of broad multi-country molecular surveillance","volume":"73","author":"Borges","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/09564624211048662","article-title":"Whole-genome sequencing of Chlamydia trachomatis isolates from persistently infected patients","volume":"33","author":"Pitt","year":"2022","journal-title":"Int. J. STD AIDS"},{"key":"ref_108","first-page":"CD010871","article-title":"Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women","volume":"1","author":"Alzate","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: A systematic review","volume":"19","author":"Emerson","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_110","first-page":"689","article-title":"Azithromycin as a treatment for Chlamydia trachomatis?","volume":"154","year":"2018","journal-title":"Gac. Med. Mex."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107183","DOI":"10.1016\/j.actatropica.2024.107183","article-title":"Diversity and genetic characterization of Chlamydia isolated from Siamese crocodiles (Crocodylus siamensis)","volume":"253","author":"Chaiwattanarungruengpaisan","year":"2024","journal-title":"Acta Trop."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Marti, H., Suchland, R.J., and Rockey, D.D. (2022). The impact of lateral gene transfer in Chlamydia. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.861899"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Unterweger, C., Schwarz, L., Jelocnik, M., Borel, N., Brunthaler, R., Inic-Kanada, A., and Marti, H. (2020). Isolation of tetracycline-resistant Chlamydia suis from a pig herd affected by reproductive disorders and conjunctivitis. Antibiotics, 9.","DOI":"10.3390\/antibiotics9040187"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Bommana, S., and Polkinghorne, A. (2019). Mini review: Antimicrobial control of Chlamydial infections in animals: Current practices and issues. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00113"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7589\/2019-11-275","article-title":"Prevalence of Chlamydiaceae and tetracycline resistance genes in wild boars of Central Europe","volume":"56","author":"Wahdan","year":"2020","journal-title":"J. Wildl. Dis."},{"key":"ref_116","first-page":"151","article-title":"Chlamydia suis and tetracycline resistance genes in Italian wild boar (Sus scrofa)","volume":"57","author":"Morandi","year":"2021","journal-title":"Vet. Ital."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/1873-3468.12353","article-title":"Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria","volume":"590","author":"Shima","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/apm.12924","article-title":"Chlamydia pneumoniae enhances Interleukin 8 (IL-8) production with reduced azithromycin sensitivity under hypoxia","volume":"127","author":"Matsuo","year":"2019","journal-title":"APMIS"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/imcb.12285","article-title":"Chlamydia-infected macrophages are resistant to azithromycin treatment and are associated with chronic oviduct inflammation and hydrosalpinx development","volume":"97","author":"Harvie","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0928-0197(94)90042-6","article-title":"Re-examination of the McCoy cell line for confirmation of its mouse origin: Karyotyping, electron microscopy and reverse transcriptase assay for endogenous retrovirus","volume":"2","author":"Fong","year":"1994","journal-title":"Clin. Diagn. Virol."},{"key":"ref_121","first-page":"644","article-title":"A comprehensive review of Hep-2 cell line in translational research for laryngeal cancer","volume":"9","author":"Gorphe","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/428290","article-title":"Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: A meeting report","volume":"191","author":"Wang","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/4611","article-title":"Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs","volume":"23","author":"Mestrovic","year":"2018","journal-title":"Front. Biosci. Landmark Ed."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Benamri, I., Azzouzi, M., Sanak, K., Moussa, A., and Radouani, F. (2021). An overview of genes and mutations associated with Chlamydiae species\u2019 resistance to antibiotics. Ann. Clin. Microbiol. Antimicrob., 20.","DOI":"10.1186\/s12941-021-00465-4"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A","article-title":"Chlamydia trachomatis infection as a risk factor for invasive cervical cancer","volume":"85","author":"Koskela","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_126","first-page":"508","article-title":"Chlamydia infection as a risk factor for cervical cancer: A systematic review and meta-analysis","volume":"51","author":"Safian","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0253-7184.156680","article-title":"Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections","volume":"36","author":"Krupp","year":"2015","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11596-017-1704-1","article-title":"Biological effects of chlamydiaphage phiCPG1 capsid protein Vp1 on chlamydia trachomatis in vitro and in vivo","volume":"37","author":"Wang","year":"2017","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e965076","DOI":"10.4161\/21597073.2014.965076","article-title":"Evidence for horizontal gene transfer between Chlamydophila pneumoniae and Chlamydia phage","volume":"4","author":"Rosenwald","year":"2014","journal-title":"Bacteriophage"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00203-013-0912-8","article-title":"Chlamydia bacteriophages","volume":"195","author":"Pawlikowska","year":"2013","journal-title":"Arch. Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1574-695X.2011.00795.x","article-title":"Influence of the Chlamydia pneumoniae AR39 bacteriophage CPAR39 on chlamydial inclusion morphology","volume":"62","author":"Christiansen","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.virol.2008.05.001","article-title":"Behind the chlamydial cloak: The replication cycle of chlamydiaphage Chp2, revealed","volume":"377","author":"Salim","year":"2008","journal-title":"Virology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2019.04.008","article-title":"The phiCPG1 chlamydiaphage can infect Chlamydia trachomatis and significantly reduce its infectivity","volume":"267","author":"Wei","year":"2019","journal-title":"Virus Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/bact.20757","article-title":"The strange history of phage therapy","volume":"2","author":"Summers","year":"2012","journal-title":"Bacteriophage"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy--history from Twort and d\u2019Herelle through Soviet experience to current approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1057\/s41599-020-0478-4","article-title":"Phage therapy as a potential solution in the fight against AMR: Obstacles and possible futures","volume":"6","author":"Brives","year":"2020","journal-title":"Palgrave Commun."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Principi, N., Silvestri, E., and Esposito, S. (2019). Advantages and limitations of bacteriophages for the treatment of bacterial infections. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00513"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12223-016-0471-x","article-title":"Bacteriophages and its applications: An overview","volume":"62","author":"Sharma","year":"2017","journal-title":"Folia Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"110155","DOI":"10.1016\/j.virol.2024.110155","article-title":"Characterization of an Escherichia coli phage Tequatrovirus YZ2 and its application in bacterial wound infection","volume":"597","author":"Wang","year":"2024","journal-title":"Virology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/lam.12074","article-title":"Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation","volume":"57","author":"Tomat","year":"2013","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: A randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.pmbts.2023.03.011","article-title":"Phages for treatment of Escherichia coli infections","volume":"200","author":"Nikulin","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Pakbin, B., Br\u00fcck, W.M., and Rossen, J.W.A. (2021). Virulence factors of enteric pathogenic Escherichia coli: A review. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202108.0348.v1"},{"key":"ref_145","first-page":"840","article-title":"Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn\u2019s disease","volume":"11","author":"Galtier","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ecco-jcc\/jjac064","article-title":"Safety and efficacy of an AIEC-targeted bacteriophage cocktail in a mice colitis model","volume":"16","author":"Rousseaux","year":"2022","journal-title":"J. Crohns Colitis"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/9\/1515\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:58:26Z","timestamp":1760111906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/9\/1515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":146,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["medicina60091515"],"URL":"https:\/\/doi.org\/10.3390\/medicina60091515","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}